Skip to main content

Author: Customer Service

Enjoy a Fashion Spectacle Inspired by “One Car Two Vibes” at the Launch of the C5 SHS-H

Vietnam O5 Launch (1)Vietnam O5 Launch (1)Vietnam O5 Launch 3Vietnam O5 Launch 3Vietnam O5 Launch 4Vietnam O5 Launch 4Vietnam O5 Launch 7Vietnam O5 Launch 7WUHU, China, April 03, 2026 (GLOBE NEWSWIRE) — Recently, the Omoda C5 SHS-H was introduced in a truly distinctive way. The vehicle appeared within a space designed like a runway, where lighting, music, and movement came together to tell a story – a story about the lifestyle of a new generation, where technology and individuality coexist. From the very first steps on the runway, the event set the tone for a unique experience. The stage was split into two contrasting color zones – blue and red – symbolizing two emotional states, two personalities, two “vibes” existing within a unified whole. At the center of the stage, the C5...

Continue reading

Ipsen announces that Beech Tree has obtained an exemption from the obligation to submit a public tender offer

PARIS, FRANCE, 3 April 2026 — Ipsen (Euronext: IPN; ADR: IPSEY) announces that Beech Tree — which directly and indirectly holds 26.03% of Ipsen S.A.’s share capital and 33.05% of its voting rights — has obtained from the French Financial Markets Authority (Autorité des marchés financiers) an exemption from the obligation to file a public tender offer for all Ipsen S.A. shares.1 This decision is part of the transfer of Mr. Henri Beaufour’s stake in Beech Tree to the Alasol Foundation. This transfer is accompanied by a governance agreement between Altawin, the Alasol Foundation, and Beech Tree2 which essentially provides for: the commitment of the Alasol Foundation to retain its Beech Tree shares for a minimum period of 15 years, corresponding to the initial duration of the agreement, and not to interfere in Beech Tree’s management of...

Continue reading

OwlTing Group (NASDAQ: OWLS) Receives US$10 Million Investment with up to US$50 Million in Total Funding Available Upon Mutual Consent

Initial US$10 million funding at closing; facility provides for up to US$40 million in follow-on investments on similar terms, subject to mutual consent Zero-interest convertible security with a fixed conversion price of US$9.00 per share, representing a premium to recent trading levels Proceeds to support global expansion of OwlPay payment infrastructure, regulatory licensing, and strategic growth initiativesARLINGTON, Va., April 03, 2026 (GLOBE NEWSWIRE) — OwlTing Group (NASDAQ: OWLS) (“OwlTing” or the “Company”), the operating brand of OBOOK Holdings Inc., a global fintech company, today announced that it has entered into a Securities Purchase Agreement (the “SPA”) with Lind Global Asset Management XV LLC (the “Investor”), an investment fund managed by The Lind Partners, a New York-based institutional fund manager, for the...

Continue reading

Stallion Uranium Reports Serious Injury Incident Involving Two Contractors at Moonlite Project

VANCOUVER, British Columbia, April 02, 2026 (GLOBE NEWSWIRE) — Stallion Uranium Corp. (the “Company” or “Stallion”) (TSX-V: STUD; OTCQB: STLNF; FSE: B76) deeply regrets to report that yesterday morning, April 1, 2026, two contractors working on a surface drilling rig were seriously injured following an isolated incident at the Company’s Moonlite Project in Northern SK, Canada. The Company is working closely with local and government authorities to complete an investigation and comprehensive review of the recent situation. As a precautionary measure, drilling operations at the site have been temporarily suspended. Matthew Schwab, CEO and Director, said, “We are profoundly saddened by this incident and extend our deepest condolences and full support to the two injured contractors, their families, friends, and colleagues during this...

Continue reading

Conavi Medical Announces Results from Its Annual General Meeting of Shareholders

TORONTO, April 02, 2026 (GLOBE NEWSWIRE) — Conavi Medical Corp. (TSXV: CNVI; OTCQB: CNVIF) (“Conavi Medical” or the “Company”), a commercial stage medical device company focused on designing, manufacturing, and marketing imaging technologies to guide common minimally invasive cardiovascular procedures, announced today the results of its annual general meeting of shareholders held virtually on March 31, 2026 (the “Meeting”), as well as the adoption of amendments to the Company’s Stock Option Plan. A total of 54,352,402 common shares were voted in connection with the Meeting, representing approximately 52.56% of the issued and outstanding common shares of the Company. Each of the seven nominees listed in the management information circular of the Company (the “Circular”) dated February 17, 2026, namely, Thomas Looby, Aaron Davidson,...

Continue reading

Mattr Announces Closing of Credit Facility Extension

TORONTO, April 02, 2026 (GLOBE NEWSWIRE) — Mattr Corp. (“Mattr” or the “Company”) (TSX: MATR) announced that it has successfully closed on an amendment to its credit facility with The Toronto-Dominion Bank and National Bank of Canada as co-lead arrangers and Royal Bank of Canada, JP Morgan Chase Bank, Export Development Canada and ATB Financial as lenders to extend the US$300 million senior secured revolving facility until October 2030. “The extension of our credit facility further strengthens our balance sheet and provides us with additional long‑term financial flexibility despite market uncertainties,” said Tom Holloway, Mattr’s SVP Finance and CFO. “With this extended maturity and ample liquidity, we are well positioned to continue executing our strategy, support disciplined capital allocation, and pursue value‑accretive growth...

Continue reading

Diversified Royalty Corp. Announces April 2026 Cash Dividend

VANCOUVER, British Columbia, April 02, 2026 (GLOBE NEWSWIRE) — Diversified Royalty Corp. (TSX: DIV, DIV.DB.A and DIV.DB.B) (the “Corporation” or “DIV”) is pleased to announce that its board of directors has approved a cash dividend of $0.02375 per common share for the period of April 1, 2026 to April 30, 2026, which is equal to $0.285 per common share on an annualized basis. The dividend will be paid on April 30, 2026 to shareholders of record as of the close of business on April 15, 2026. About Diversified Royalty Corp. DIV is a multi-royalty corporation, engaged in the business of acquiring top-line royalties from well-managed multi-location businesses and franchisors in North America. DIV’s objective is to acquire predictable, growing royalty streams from a diverse group of multi-location businesses and franchisors. DIV currently...

Continue reading

Weatherford Announces Proposal to Redomesticate to the United States, Establishing Texas as New Legal Domicile

Move reflects continued execution of Weatherford’s free-cash-flow-focused strategy to streamline corporate structure, enhance capital management flexibility and deliver long-term shareholder value HOUSTON, April 02, 2026 (GLOBE NEWSWIRE) — Weatherford International plc (NASDAQ: WFRD) (“Weatherford” or the “Company”) today announced its proposal to reorganize the Company’s corporate structure by redomesticating its parent company from Ireland to the United States, with Texas as the parent company’s new legal home. The proposed redomestication is expected to be completed in the third quarter of 2026, subject to shareholder and other customary approvals for a transaction of this type. Weatherford’s global operational headquarters has been located in Houston for more than two decades, and the Company maintains a substantial operational,...

Continue reading

Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company as of March 31, 2026

Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company as of March 31, 2026 (Article 223-16 of the General Regulations of the Autorité des Marchés Financiers) Market : NYSE Euronext Paris ISIN Code: FR 0010417345  Date   Total number of shares Total number of voting rights03/31/2026   296,042,447     Total gross of voting rights: 296,042,447    Total net* of voting rights: 295,914,379  * Net total = total number of voting rights attached to shares – shares without voting rightsAttachmentPDF Version

Continue reading

Esperion Therapeutics Closes Acquisition of Corstasis Therapeutics, Expanding Its Cardiovascular Franchise with Enbumyst™ (bumetanide nasal spray)

– Enbumyst, First and Only FDA-Approved Nasal Spray Loop Diuretic Now Integrated into Esperion’s Cardiovascular Franchise, Anticipated to Drive Portfolio Expansion, Commercial Leverage, and Continued Revenue Growth – ANN ARBOR, Mich., April 02, 2026 (GLOBE NEWSWIRE) — Esperion (NASDAQ: ESPR) (the Company) today announced the closing of its acquisition of Corstasis Therapeutics Inc., a privately-held, commercial-stage biopharmaceutical company advancing innovative outpatient therapies for the treatment of edema associated with cardiovascular and hepatic and renal disease. “The closing of this acquisition marks an important milestone in advancing our Vision 2040 and strengthens our commitment to delivering differentiated therapies that address the growing global burden of cardiometabolic disease,” said Sheldon Koenig, President and...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.